Literature DB >> 4005167

The prevalence of accentuated palmoplantar markings and keratosis pilaris in atopic dermatitis, autosomal dominant ichthyosis and control dermatological patients.

B Mevorah, A Marazzi, E Frenk.   

Abstract

The prevalence of keratosis pilaris and accentuated palmoplantar marking was evaluated in 61 patients with atopic dermatitis, 35 patients with dominant ichthyosis vulgaris and 247 other dermatological cases taken as controls. Our data showed that (1) these features are of no diagnostic significance for atopic dermatitis and (2) they are significantly more frequent in patients with ichthyosis vulgaris without associated eczema than in those with atopic dermatitis. Consequently, they should be considered as part of the phenotype of ichthyosis vulgaris rather than attributed to a concomitant atopic dermatitis as suggested by some. These findings should be taken into account when evaluating atopic dermatitis or ichthyosis. To assess the frequency of scaling under winter weather conditions, 155 control subjects were also examined for evidence of visible desquamation and 25.8% showed slight but definite scaling.

Entities:  

Mesh:

Year:  1985        PMID: 4005167     DOI: 10.1111/j.1365-2133.1985.tb02336.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  13 in total

1.  Sebaceous gland, hair shaft, and epidermal barrier abnormalities in keratosis pilaris with and without filaggrin deficiency.

Authors:  Robert Gruber; Jeffrey L Sugarman; Debra Crumrine; Melanie Hupe; Theodora M Mauro; Elizabeth A Mauldin; Jacob P Thyssen; Johanna M Brandner; Hans-Christian Hennies; Matthias Schmuth; Peter M Elias
Journal:  Am J Pathol       Date:  2015-02-07       Impact factor: 4.307

2.  Ultrastructural study of the occurrence of autosomal dominant ichthyosis vulgaris in atopic eczema.

Authors:  M Fartasch; E Haneke; I Anton-Lamprecht
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

3.  [Associated diseases and differential diagnostic considerations in childhood atopic eczema].

Authors:  C Jenneck; R Foelster-Holst; T Hagemann; N Novak
Journal:  Hautarzt       Date:  2007-02       Impact factor: 0.751

4.  Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function.

Authors:  Robert Gruber; Peter M Elias; Debra Crumrine; Tzu-Kai Lin; Johanna M Brandner; Jean-Pierre Hachem; Richard B Presland; Philip Fleckman; Andreas R Janecke; Aileen Sandilands; W H Irwin McLean; Peter O Fritsch; Michael Mildner; Erwin Tschachler; Matthias Schmuth
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

5.  Epidemiology and clinical features of atopic dermatitis in India.

Authors:  Amrinder J Kanwar; Dipankar De
Journal:  Indian J Dermatol       Date:  2011 Sep-Oct       Impact factor: 1.494

Review 6.  One remarkable molecule: filaggrin.

Authors:  Sara J Brown; W H Irwin McLean
Journal:  J Invest Dermatol       Date:  2011-12-08       Impact factor: 8.551

7.  Filaggrin haploinsufficiency is highly penetrant and is associated with increased severity of eczema: further delineation of the skin phenotype in a prospective epidemiological study of 792 school children.

Authors:  S J Brown; C L Relton; H Liao; Y Zhao; A Sandilands; W H I McLean; H J Cordell; N J Reynolds
Journal:  Br J Dermatol       Date:  2009-06-11       Impact factor: 9.302

8.  Keratosis pilaris revisited: is it more than just a follicular keratosis?

Authors:  Mary Thomas; Uday Sharadchandra Khopkar
Journal:  Int J Trichology       Date:  2012-10

Review 9.  Disorders of keratinisation: from rare to common genetic diseases of skin and other epithelial tissues.

Authors:  W H Irwin McLean; Alan D Irvine
Journal:  Ulster Med J       Date:  2007-05

10.  Keratosis pilaris and prevalence of acne vulgaris: a cross-sectional study.

Authors:  Juliano Vilaverde Schmitt; Brunno Zeni de Lima; Monique Carolina Meira do Rosário de Souza; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.